Diversion Control Division, US Department of Justice, Drug Enforcement Administration

ABOUT US > What's New

What's New

December

Usona Institute (December 14, 2018)

Arizona Department of Corrections (December 14, 2018)

Usona Institute (December 14, 2018)

Eli-Elsohly Laboratories (December 13, 2018)

Cambrex High Point, Inc. (December 13, 2018)

Siegfried USA, LLC (December 13, 2018)

Mylan Pharmaceuticals Inc. (December 13, 2018)

Noramco Inc. (December 13, 2018)

Mylan Technologies, Inc. (December 13, 2018)

Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2018 (December 10, 2018)

Bulk Manufacturer of Controlled Substances Registration (December 6, 2018)

Decision and Order: Zelideh I. Cordova-Velazco, M.D. (December 6, 2018)

Exempt Chemical Preparations Under the Controlled Substances Act (December 3, 2018)


November

Steve Fanto, M.D.; Decision and Order (November 30, 2018)

Narciso A. Reyes, M.D.; Decision and Order (November 30, 2018)

Final Order: Placement of Furanyl Fentanyl, 4-Fluoroisobutyryl Fentanyl, Acryl Fentanyl, Tetrahydrofuranyl Fentanyl, and Ocfentanil in Schedule I (November 29, 2018)

Importer of Controlled Substances Registration (November 27, 2018)

Bulk Manufacturer of Controlled Substances Registration (November 27, 2018)

Importer of Controlled Substances Registration (November 27, 2018)

Noramco Inc. (November 27, 2018)

Insys Manufacturing, LLC (November 27, 2018)

Cayman Chemical Company (November 27, 2018)

Akorn, Inc. (November 27, 2018)

Cambridge Isotope Laboratories (November 27, 2018)

GE Healthcare (November 27, 2018)

Fisher Clinical Services, Inc. (November 27, 2018)

Sigma Aldrich Co., LLC (November 27, 2018)

Organix, Inc. (November 20, 2018)

Patheon API Manufacturing, Inc. (November 20, 2018)

Edward A. Ridgill, M.D.; Decision and Order (November 20, 2018)

Eldor Brish, M.D.; Decision and Order (November 20, 2018)

Lipomed (November 20, 2018)

Janssen Pharmaceuticals Inc. (November 20, 2018)

Bulk Manufacturer of Controlled Substances Registration (November 9, 2018)

Chattem Chemicals (November 9, 2018)

Bulk Manufacturer of Controlled Substances Registration (November 2, 2018)

Janssen Pharmaceuticals, Inc. (November 2, 2018)


October

Importer of Controlled Substances Registration (October 30, 2018)

Bulk Manufacturer of Controlled Substances Registration (October 30, 2018)

Insys Manufacturing, LLC (October 30, 2018)

Sigma Aldrich Research (October 30, 2018)

Eric Lee Knight, M.D.; Decision and Order (October 30, 2018)

Cambrex High Point, Inc. (October 30, 2018)

United States Pharmacopeial Convention (October 30, 2018)

Sharp (Bethlehem), LLC (October 30, 2018)

Fisher Clinical Services, Inc. (October 30, 2018)

Catalent CTS, LLC (October 30, 2018)

Hisham M. Shawish, M.D.; Decision and Order (October 25, 2018)

Bulk Manufacturer of Controlled Substances Registration (October 19, 2018)

Importer of Controlled Substances Registration (October 19, 2018)

Noramco Inc. (October 19, 2018)

Fisher Clinical Services, Inc. (October 19, 2018)

Importer of Controlled Substances Registration (October 15, 2018)

Specgx, LLC (October 15, 2018)

Phillip O. Rawlings, Jr., M.D.; Decision and Order (October 15, 2018)

Cambrex High Point, Inc. (October 15, 2018)

Bulk Manufacturer of Controlled Substances Registration (October 2, 2018)

Importer of Controlled Substances Registration (October 2, 2018)

Importer of Controlled Substances Registration (October 2, 2018)

Rhodes Technologies (Correction) (October 2, 2018)

AMPAC Fine Chemicals, LLC (October 2, 2018)

Cambrex Charles City (October 2, 2018)

R & D Systems, Inc. (October 2, 2018)


September

Schedules of Controlled Substances: Placement in Schedule V of Certain FDA-Approved Drugs Containing Cannabidiol; Corresponding Change to Permit Requirements (September 28, 2018)

Nanosyn, Inc. (September 27, 2018)

Absolute Standards, Inc. (September 27, 2018)

Halo Pharmaceutical, Inc. (September 24, 2018)

AMPAC Fine Chemicals Virginia, LLC (September 24, 2018)

Sharon C. Worosilo, M.D., Decision and Order (September 19, 2018)

Brian Thomas Nichol, M.D., Decision and Order (September 19, 2018)

Alcami Carolinas Corporation (September 14, 2018)

Bulk Manufacturer of Controlled Substances Registration (September 7, 2018)


August

Temporary Placement of N-Ethylpentylone in Schedule I (August 31, 2018)

National Center for Natural Products Research NIDA MPROJECT (August 31, 2018)

Importer of Controlled Substances Registration (August 23, 2018)

Greg N. Rampey, D.O.; Dismissal of Proceedings (August 23, 2018)

Proposed Adjustments to the Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2018 (August 23, 2018)

Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2019 (August 20, 2018)

Houston Maintenance Clinic; Decision and Order (August 20, 2018)

Rhodes Technologies (August 15, 2018)

Bharanidharan Padmanabhan, M.D., Ph.D.; Decision and Order (August 10, 2018)

Importer of Controlled Substances Registration (August 8, 2018)

Clinical Supplies Management Holdings, Inc. (August 8, 2018)

AndersonBrecon Inc. (August 8, 2018)

Chattem Chemicals, Inc. (August 8, 2018)

Myoderm (August 8, 2018)

Euticals Inc. (August 8, 2018)

30-Day Notice: The National Forensic Laboratory Information System Collection of Drug Analysis Data (August 6, 2018)

AMRI Rensselaer, Inc. (August 3, 2018)

Chemtos, LLC (August 1, 2018)

Cody Laboratories Inc. (August 1, 2018)

Galephar Pharmaceutical Research Inc. (August 1, 2018)

Ultra Scientific Inc. (August 1, 2018)

Anderson Brecon, Inc. (August 1, 2018)


July

Craig S. Morris, DDS; Dismissal of Proceeding (July 31, 2018)

Bulk Manufacturer of Controlled Substances Registration (July 26, 2018)

Importer of Controlled Substances Registration (July 23, 2018)

Decision and Order: Kenneth C. Beal, Jr., D.D.S. (July 23, 2018)

Fisher Clinical Services, Inc. (July 23, 2018)

Importer of Controlled Substances Registration (July 23, 2018)

Catalent Pharma Solutions, LLC (July 23, 2018)

VHG Labs DBA LGC Standards (July 23, 2018)

Fresenius Kabi USA, LLC (July 23, 2018)

Shertech Laboratories, LLC (July 23, 2018)

Johnson Matthey Inc. (July 23, 2018)

Final Rule: Controlled Substances Quotas (July 16, 2018)

Siegfried USA, LLC (July 16, 2018)

Cerilliant Corporation (July 16, 2018)

Temporary Scheduling Order: Temporary Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA Into Schedule I (July 10, 2018)

S & B Pharma, Inc. (July 5, 2018)

Ljudmil Kljusev, M.D.; Decision and Order (July 2, 2018)

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility